RAD140: Natty or Not? | Still Natty Abstract gradient background for Still Natty peptides guide
Back to Peptides

RAD140

Not Natty
sarmmuscle gainbreast canceroral

What It Does

Increases muscle and bone mass. Weight gain up to 10% in 28 days. Risk of liver damage and testosterone suppression.

Not Natty Classification

This peptide is classified as NOT natty. It is prohibited by WADA (World Anti-Doping Agency) and most natural bodybuilding federations. Using this compound would place you in the 'enhanced' category rather than natural/natty status in competitive contexts.

Description

SARM (RAD140) for breast cancer trials. Tissue-selective AR modulator. Liver toxicity risk, testosterone suppression. Not FDA-approved, banned in sports.

Application Methods

  • Oral

Product Names

  • Vosilasarm
  • EP0062

Benefits

  • High androgen receptor affinity (Ki = 7 nM)
  • Tissue-selective: anabolic in muscle/bone, anti-proliferative in breast
  • Clinical benefit in 21% of heavily pre-treated breast cancer patients
  • 58% stable disease rate in breast cancer trials
  • 26% showed marked CA15-3 tumor marker suppression
  • 90% as anabolic as testosterone in preclinical studies
  • >10% weight gain in 28 days in primate models (0.1mg/kg)
  • Oral administration (no injections)
  • Good selectivity over other steroid hormone receptors
  • Reformulated EP0062 has improved bioavailability

Dosage Levels

  • Clinical trials (breast cancer): 50-150mg daily oral
  • Maximum tolerated dose: 100mg daily
  • Phase 2 recommended dose: 10mg twice daily (20mg total)
  • Black market use (not recommended): 5-30mg daily
  • Note: Non-medical use is illegal and dangerous
  • Clinical dosing should only be under medical supervision
  • Liver function monitoring required during use

Related Peptides

Looking for Natty Alternatives?

Since this peptide is classified as not natty, here are some natty-approved options you might consider:

Last Updated: 10/19/2025